BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7947290)

  • 1. Possible role of granulocyte-macrophage colony stimulating factor (GM-CSF) on the rapid progression of AIDS-related Kaposi's sarcoma lesions in vivo.
    Hermans P; Gori A; Lemone M; Franchioly P; Clumeck N
    Br J Haematol; 1994 Jun; 87(2):413-4. PubMed ID: 7947290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired immune deficiency syndrome-related Kaposi's sarcoma.
    Krown SE
    J Clin Oncol; 1991 Dec; 9(12):2235-7. PubMed ID: 1960565
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous Kaposi's sarcoma. Thallium scan demonstration.
    Lee VW; Chen H; Panageas E; O'Keane JC; Liebman HA
    Clin Nucl Med; 1990 Aug; 15(8):569-71. PubMed ID: 2390823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
    Bakker PJ; Danner SA; ten Napel CH; Kroon FP; Sprenger HG; van Leusen R; Meenhorst PL; Muusers A; Veenhof CH
    Eur J Cancer; 1995; 31A(2):188-92. PubMed ID: 7536434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment helpful in Kaposi's sarcoma.
    Nurs Stand; 1993 May 19-25; 7(35):17. PubMed ID: 8499297
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchopulmonary Kaposi's sarcoma in patients with AIDS.
    Mitchell DM; McCarty M; Fleming J; Moss FM
    Thorax; 1992 Sep; 47(9):726-9. PubMed ID: 1440468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma of the head and neck in patients with acquired immunodeficiency syndrome.
    Singh B; Har-el G; Lucente FE
    Otolaryngol Head Neck Surg; 1994 Nov; 111(5):618-24. PubMed ID: 7970801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keloidal Kaposi's sarcoma: report of three patients.
    Schwartz RA; Spicer MS; Janniger CK; Cohen PJ; Melczer MM; Lambert WC
    Dermatology; 1994; 189(3):271-4. PubMed ID: 7949482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome.
    Glassman SJ; Hale MJ
    Clin Exp Dermatol; 1995 Nov; 20(6):480-6. PubMed ID: 8857342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kaposi's sarcoma as the first manifestation of AIDS].
    Betlloch Mas I; Jiménez Martínez A; Ramón Quiles D; Castells Rodellas A
    Med Cutan Ibero Lat Am; 1987; 15(2):98-104. PubMed ID: 3309505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous acquired immunodeficiency syndrome-associated Kaposi's sarcoma in pediatric patients.
    Connor E; Boccon-Gibod L; Joshi V; Just J; Grimfeld A; Morrison S; McSherry G; Oleske J
    Arch Dermatol; 1990 Jun; 126(6):791-3. PubMed ID: 2346323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.
    Costello RT
    Acta Oncol; 1993; 32(4):403-8. PubMed ID: 8369127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma.
    Boente P; Sampaio C; Brandão MA; Moreira ED; Badaro R; Jones TC
    Lancet; 1993 May; 341(8853):1154. PubMed ID: 8097837
    [No Abstract]   [Full Text] [Related]  

  • 20. Lympho-cutaneous Kaposi's sarcoma in an African pediatric AIDS case.
    Bouquety JC; Siopathis MR; Ravisse PR; Lagarde N; Georges-Courbot MC; Georges AJ
    Am J Trop Med Hyg; 1989 Mar; 40(3):323-5. PubMed ID: 2929857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.